ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.630,44
0,41%
S&P 500
5.487,03
0,25%
US Dollar vs BRL
5,4413
0,00%
Bitcoin
65.508,46
0,57%
Brent Oil
84,805
0,02%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Amylyx Pharmaceuticals Inc (AMLX)

  7. Amylyx Pharmaceuticals Inc (AMLX) Notícias

AMLX Amylyx Pharmaceuticals Inc

1,66
0,01 (0,61%)
18 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Amylyx Pharmaceuticals Inc AMLX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,01 0,61% 1,66 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,62 1,62 1,67 1,62 1,65
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/06/202410:00BWAmylyx Pharmaceuticals to Present at the Goldman Sachs 45th..
09/05/202408:00BWAmylyx Pharmaceuticals Reports First Quarter 2024 Financial..
08/05/202410:00BWAmylyx Pharmaceuticals to Present at the 2024 Bank of..
02/05/202410:00BWAmylyx Pharmaceuticals to Report First Quarter 2024..
10/04/202410:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/04/202406:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/04/202410:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/04/202406:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/04/202408:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/04/202406:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/03/202406:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/03/202406:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/03/202409:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/03/202406:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/03/202406:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
14/03/202410:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/03/202406:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/03/202406:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/03/202409:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
07/03/202407:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
26/02/202407:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
23/02/202418:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
22/02/202409:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/02/202407:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
15/02/202418:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
15/02/202411:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/02/202407:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
08/02/202411:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
22/12/202311:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
04/12/202311:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
29/11/202319:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202309:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
27/11/202311:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
21/11/202311:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
09/11/202309:00BWAmylyx Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202310:00BWAmylyx Pharmaceuticals to Report Third Quarter 2023..
19/10/202310:00BWAmylyx Pharmaceuticals to Present Clinical Trial Design of..
13/10/202308:45BWAmylyx Pharmaceuticals Receives Negative CHMP Opinion on its..
10/10/202310:12BWAmylyx Pharmaceuticals Announces Publication of Survival..
05/10/202318:26BWAmylyx Pharmaceuticals Provides Update on Accès..
02/10/202310:00BWRELYVRIO® and AMX0114 Data to be Presented at 22nd Annual..
05/09/202310:00BWAmylyx Pharmaceuticals to Participate in Upcoming Investor..
10/08/202317:01BWAmylyx Pharmaceuticals Reports Second Quarter 2023 Financial..
03/08/202317:05BWAmylyx Pharmaceuticals to Report Second Quarter 2023..
12/07/202310:00BWAmylyx Pharmaceuticals to Host Virtual Webcast on AMX0035..
23/06/202309:14BWAmylyx Pharmaceuticals Receives CHMP Negative Opinion on its..

Seu Histórico Recente

NASDAQ
AMLX
Amylyx Pharmaceuticals
BIT
SLUX5L
Societe Generale Effekten
BIT
P1LNE3
BNP Paribas Issuance
EU
AUTZL
Amundi Finance Emissions...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados